¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"vascular hypertension"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pregnancy-induced hypertension
    ÀӽŰíÇ÷¾Ð
  • primary hypertension
    ¿ø¹ß¼º°íÇ÷¾Ð
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð, ÇãÆÄµ¿¸Æ°íÇ÷¾Ð
  • renal hypertension
    ÄáÆÏ°íÇ÷¾Ð, ½ÅÀ强°íÇ÷¾Ð
  • renovascular hypertension
    ÄáÆÏÇ÷°ü°íÇ÷¾Ð, ½ÅÀåÇ÷°ü°íÇ÷¾Ð
  • stasis hypertension
    ¿ïÇ÷°íÇ÷¾Ð
  • secondary hypertension
    ÀÌÂ÷°íÇ÷¾Ð
  • sinusoidal hypertension
    ±¼Ç÷°ü°íÇ÷¾Ð
  • articular vascular network
    °üÀýÇ÷°ü±×¹°, °üÀýÇ÷°ü¸Á
  • collagen-vascular disease
    Äݶó°ÕÇ÷°üº´, ±³¿øÇ÷°üº´
  • concentric vascular bundle
    µ¿½É¸Æ°ü´Ù¹ß
  • coronary vascular resistance
    °ü»óÇ÷°üÀúÇ×, ½ÉÀåÇ÷°üÀúÇ×
  • cerebral vascular resistance
    ³úÇ÷°üÀúÇ×
  • hypertensive vascular disease
    °íÇ÷¾ÐÇ÷°üº´
  • pulmonary vascular resistance
    ÆóÇ÷°üÀúÇ×
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inner vascular web
    ³»Ç÷°ü¸Á
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð, ÇãÆÄ°íÇ÷¾Ð
  • rebound hypertension
    ¹Ýµ¿°íÇ÷¾Ð
  • red hypertension
    È«Á¶°íÇ÷¾Ð, ºÓÀº°íÇ÷¾Ð
  • renal hypertension
    ÄáÆÏ°íÇ÷¾Ð
  • renovascular hypertension
    ÄáÆÏÇ÷°ü°íÇ÷¾Ð
  • secondary hypertension
    ÀÌÂ÷°íÇ÷¾Ð
  • stasis hypertension
    ¿ïÇ÷°íÇ÷¾Ð
  • ocular hypertension indicator
    ¾È±¸°íÇ÷¾ÐÁöÇ¥
  • articular vascular network
    °üÀý¸Æ°ü±×¹°
  • concentric vascular bundle
    µ¿½É¸Æ°ü´Ù¹ß
  • splanchnic vascular bed
    ³»ÀåÇ÷°ü¿µ¿ª
  • vascular bed
    Ç÷°ü»ó, Ç÷°ü¹ÙÅÁ
  • cerebral vascular resistance
    ³úÇ÷°üÀúÇ×
  • collagen-vascular disease
    ¾Æ±³ÁúÇ÷°üº´, ±³¿øÇ÷°üº´
  • coronary vascular resistance
    ½ÉÀåÇ÷°üÀúÇ×, °ü»óÇ÷°üÀúÇ×
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • accelerated hypertension
    °¡¼Ó¼º °íÇ÷¾Ð.
  • adrenal hypertension
    ºÎ½Å¼º °íÇ÷¾ÐÁõ(¡­ÍÔúìäâñø).
  • arterial hypertension
    µ¿¸Æ(¼º) °íÇ÷¾Ð(Áõ).
  • hypertension
    °íÇ÷¾Ð(Áõ)(ÍÔúìäâñø), ±äÀåÇ×Áø(Áõ)(ÑÌíåùñòäñø).
  • hypertension
    °íÇ÷¾Ð(Áõ)(ÍÔúìäâ)
  • hypertension cranienne ºÒ
    ³ú¾ÐÇ×Áø(Áõ).
  • hypertension paroxystique ºÒ
    ¹ßÀÛ¼º °íÇ÷¾Ð(Áõ)(Û¡íÂàõÍÔúìäâñø).
  • hypertension,benign nephrosclerosis
    ¾ç¼º ½Å°æÈ­Áõ
  • hypertension,essential
    º»Å¼º(Üâ÷¾àõ)
  • hypertension,malignant
    ¾Ç¼º(äÂàõ)
  • hypertension,portal
    ¹®¸Æ¼º(Ú¦Øæàõ)
  • portal hypertension
    ¹®¸Æ¾ÐÇ×ÁøÁõ(Ú¦Øæäâùñòäñø), ¹®¸Æ°íÇ÷¾Ð(¡­ÍÔúìäâ).
  • portal hypertension
    ¹®¸Æ¾ÐÇ×ÁøÁõ(Ú¦Øæäâùñòäñø), ¹®¸Æ°íÇ÷¾Ð(Ú¦ØæÍÔúìäâ)
  • portal hypertension
    ¹®¸Æ¾ÐÇ×ÁøÁõ
  • primary hypertension
    ¿ø¹ß(¼º) °íÇ÷¾ÐÁõ (¡­ÍÔúìäâñø).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hypertension,malignant
    ¾Ç¼º(äÂàõ)
  • hypertension,portal
    ¹®¸Æ¼º(Ú¦Øæàõ)
  • intracranial hypertension
    µÎ°³³»°íÇ÷¾Ð (¡­ÍÔúìäâ).
  • juvenile hypertension
    ¿¬¼Ò¼º °íÇ÷¾Ð(Áõ).
  • kallikrein-kinin,renal hypertension
    ½Å¼º°íÇ÷¾Ð(½Å¼º ÍÔúìäâ)
  • labile hypertension
    ºÒ¾ÈÁ¤¼º °íÇ÷¾Ð (¡­ÍÔúìäâ).
  • low renin essential hypertension
    Àú·¹´Ñ¼º º»Å¼º °íÇ÷¾Ð(­àõÜâ÷¾àõÍÔúì äâ).
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾ÐÁõ(ÊÙË­Ì´ËâÌ¡).
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾ÐÁõ(¡­ÍÔúìäâñø).
  • nephrogenous hypertension
    ½Å¼º°íÇ÷¾Ð (~ÍÔúìäâ).
  • ocular hypertension
    °í¾È¾ÐÁõ
  • ocular hypertension indicator =OHI
    ¾È±¸°íÇ÷¾ÐÁöÇ¥(äÑϹÍÔúìäâò¦øö).
  • orthostatic hypertension
    ±â¸³¼º °íÇ÷¾Ð.
  • portal hypertension
    ¹®¸Æ¾ÐÇ×ÁøÁõ(Ú¦Øæäâùñòäñø), ¹®¸Æ°íÇ÷¾Ð(¡­ÍÔúìäâ).
  • portal hypertension
    ¹®¸Æ¾ÐÇ×ÁøÁõ(Ú¦Øæäâùñòäñø), ¹®¸Æ°íÇ÷¾Ð(Ú¦ØæÍÔúìäâ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Submucous vascular plexus
    Á¡¸·¹Ø¸Æ°ü¾ó±â
    [¿¾ ¿ë¾î] Á¡¸·ÇϸưüÃÑ
  • Vascular pole
    Ç÷°ü±Ø
    [¿¾ ¿ë¾î] ¸Æ°ü±Ø
  • Vascular plexus
    Ç÷°ü½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ¸Æ°ü½Å°æÃÑ
  • Vascular layer
    Ç÷°üÃþ
    [¿¾ ¿ë¾î] Ç÷°üÃþ
  • Vascular placenta
    Ç÷°üŹÝ
    [¿¾ ¿ë¾î] Ç÷°ü¼ºÅ¹Ý
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vascular malformation
    Ç÷°ü±âÇü
  • vascular pool
    Ç÷°üÇ®
  • vascular signal void
    Ç÷°ü ½ÅÈ£¼Ò½Ç, Ç÷°ü ¹«½ÅÈ£
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CVA   1) Cardio-Vascular Accident(Attack)
  2) Cerebro-Vascular Accident(Attack);...
CVD   1)  Cerebro-Vascular Disease; ½ÉÀå Ç÷°üº´(Áõ)
    = CVA
&n...
PVD patient very disturbed; peripheral vascular disease; portal vein dilation; posterior vitreous detach...
PVR peripheral vascular resistance; perspective volume rendering; poliovirus receptor; postvoiding resid...
RVR reduced vascular response; renal vascular resistance; repetitive ventricular response; resistance to...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AHT Arterial Hypertension
BIH Benign Intracranial Hypertension
BH Borderline hypertension
BHS British Hypertension Society
CT-E PH Chronic thromboembolic pulmonary hypertension
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cerebral vascular disease
    ³ú Ç÷°ü Áúȯ
  • collagen-vascular disease
    ±³¿øÁú-Ç÷°ü¼º Áúȯ
  • hepatic vascular resistance
    °£ Ç÷°ü ÀúÇ×
  • mixed muscular vascular headache
    ±Ù¸Æ°ü¼º È¥ÇÕ µÎÅë, È¥ÇÕµÈ ±Ù-Ç÷°ü¼º µÎÅë, È¥ÇÕ¼º ±ÙÀ° Ç÷°ü µÎÅë, È¥ÇÕÇü ±Ù¸Æ°ü¼º µÎÅë
  • multiple vascular tumor
    ´Ù¹ß¼º Ç÷°ü Á¾¾ç
  • non-vascular intracranial disorder
    ºñÇ÷°ü¼º µÎ°³³» Àå¾Ö
  • peripheral vascular disease
    ¸»ÃÊÇ÷°ü Áúȯ
  • peripheral vascular system
    ¸»ÃÊÇ÷°ü°è
  • renal vascular injury
    ½Å Ç÷°ü ¼Õ»ó
  • vascular
    ¸Æ°ü¼º, Ç÷°ü¼º
    Ç÷°ü¿¡ °üÇÑ. ¸Æ°üÀÇ, Ç÷°üÀÇ, Ç÷°üºÐÆ÷¼ºÀÇ. ´Ù·®ÀÇ Ç÷¾× °ø±ÞÀÌ Ç³ºÎÇÔÀ» ³ªÅ¸³»´Â.
  • vascular access
    Ç÷°ü Á¢±Ù
    Ç÷°ü Áúȯ ½Ã Áúȯ ºÎÀ§¿¡ µµ´ÞÇϱâ À§ÇÑ Á¢±Ù. ¶Ç´Â Àå±â³ª ±â°ü µîÀÇ ¼ö¼úÀ» À§ÇØ Ç÷°üÀ» ÅëÇØ º´¼Ò¿¡ µµ´ÞÇÏ´Â Á¢±Ù.
  • vascular bed
    Ç÷°ü»ó
  • vascular cecal fold
    ¸·Ã¢ÀÚ Ç÷°ü ÁÖ¸§
  • vascular change
    ¸Æ°ü¼º º¯È­
  • vascular damage
    Ç÷°ü ¼Õ»ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
primary pulmonary hypertension A condition where there is increased blood pressure in the pulmonary arteries with otherwise normal heart and lungs. The cause is unknown, but there is diffuse narrowing of the pulmonary arteries resulting in increased arteriolar pressures. Secondary heart failure ensues without correction of this problem. There is an increased incidence of this disease in females between the ages of 20 and 40 years. Treatment may include a heart and lung transplant in select cases.
(27 Sep 1997)
secondary hypertension Arterial hypertension produced by a known cause, e.g., hyperthyroidism, kidney disease, etc., in contrast to primary hypertension that is of unknown cause.
(05 Mar 2000)
pulmonary hypertension <cardiology> Abnormally elevated blood pressure within the pulmonary circuit (pulmonary artery).
Pulmonary hypertension may be secondary to another disease process (VSD, ASD, severe COAD) or occur as a primary disease process known as primary pulmonary hypertension.
(27 Sep 1997)
hypertension <cardiology> Persistently high arterial blood pressure. Hypertension may have no known cause (essential or idiopathic hypertension) or be associated with other primary diseases (secondary hypertension).
This condition is considered a risk factor for the development of heart disease, peripheral vascular disease, stroke and kidney disease.
(29 Sep 1997)
hypertension, malignant Severe hypertension characterised by papilledema and necrosis of small arteries and arterioles. The diastolic pressure is generally greater than 130 mm hg.
(12 Dec 1998)
hypertension, portal Abnormally increased pressure in the portal venous system; frequently seen in cirrhosis of the liver and in other conditions which cause obstruction of the portal vein.
(12 Dec 1998)
hypertension, pulmonary High blood pressure in the pulmonary arteries. Normally, the pressure in the pulmonary arteries is low (compared to that in the aorta). Pulmonary hypertension can irrevocably damage the lungs. Pulmonary hypertension is made up of pulmonary for lung, hyper for high, and tension for blood pressure. (in french, the word for blood pressure is tension ).
(12 Dec 1998)
hypertension, renal Hypertension due to renal diseases, especially chronic parenchymal disease. Hypertension as a result of compression or obstruction of the renal artery or its branches is hypertension, renovascular.
(12 Dec 1998)
hypertension, renovascular Hypertension due to compression or obstruction of the renal artery or its branches.
(12 Dec 1998)
neonatal pulmonary venous hypertension <radiology> With cardiomegaly, hypoplastic left heart, critical aortic stenosis, cor triatriatum, pulmonary venous atresia, normal heart size, infradiaphragmatic TAPVR
(12 Dec 1998)
systemic venous hypertension Increased pressure in the veins ultimately leading to the right atrium nearly always due to disease of the right heart but occasionally due to blockade of one or both venae cavae.
(05 Mar 2000)
idiopathic hypertension Hypertension without known cause.
Synonym: idiopathic hypertension, primary hypertension.
(05 Mar 2000)
idiopathic pulmonary hypertension <chest medicine> A condition where there is increased blood pressure in the pulmonary arteries with otherwise normal heart and lungs.
The cause is unknown, but there is diffuse narrowing of the pulmonary arteries resulting in increased arteriolar pressures. Secondary heart failure ensues without correction of this problem. There is an increased incidence of this disease in females between the ages of 20 and 40 years. Treatment may include a heart and lung transplant in select cases.
(27 Sep 1997)
intracranial hypertension Increased pressure of the cerebrospinal fluid. If symmetrically distributed it may have few neurologic symptoms (e.g., pseudotumour cerebri), but if it is asymmetrical (as in hydrocephalus), neurological symptoms are often severe.
(12 Dec 1998)
ocular hypertension A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á